4 completed. 4 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 4 |
Follow OMP-54F28: new trials by email Literature Review of OMP-54F28 trials Research Report on OMP-54F28
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dose Escalation Study of OMP-54F28 in Combination With Paclitaxel and Carboplatin in Patients With Recurrent Platinum-Sensitive Ovarian Cancer OMP-54F28, Paclitaxel and Carboplatin - Ovarian Cancer | Phase 1 | Completed | OncoMed Pharmaceuticals, Inc. | 37 | 2014-01-01 | 2020-08-12 |
| Dose Escalation Study of OMP-54F28 in Combination With Sorafenib in Patients With Hepatocellular Cancer OMP-54F28 with Sorafenib - Hepatocellular Cancer, Liver Cancer | Phase 1 | Completed | OncoMed Pharmaceuticals, Inc. | 10 | 2014-01-01 | 2020-08-11 |
| Dose Escalation Study of OMP-54F28 in Combination With Nab-Paclitaxel and Gemcitabine in Patients With Previously Untreated Stage IV Pancreatic Cancer OMP-54F28, Nab-Paclitaxel and Gemcitabine - Pancreatic Cancer, Stage IV Pancreatic Cancer | Phase 1 | Completed | OncoMed Pharmaceuticals, Inc. | 26 | 2013-11-01 | 2020-09-09 |
| A Dose Escalation Study of OMP-54F28 in Subjects With Solid Tumors OMP-54F28 - Solid Tumors | Phase 1 | Completed | OncoMed Pharmaceuticals, Inc. | 26 | 2012-06-01 | 2020-08-11 |
Liver Neoplasms (1) · Neoplasm Metastasis (1) · Neoplasms (1) · Ovarian Neoplasms (1) · Pancreatic Neoplasms (1)
OncoMed Pharmaceuticals, Inc. (4)
United States (4)